Browse and digest the latest news in neurosurgery

Message from NEUROSURGIC

Please observe that

we do not have the possibilty to

add more conferences

for the moment


Neurosurgical news

Keep yourself updated by browsing our news!

Select a news category from the menu to the right! For the latest news - login and go to the Startpage.

IMEC__.jpgNeural Probe Stimulates Individual Brain Cells

Imec, Leuven, Belgium, presents their new neural probe that can sense and stimulate single neurons in the brain. The probe consist of hundreds of small electrodes which can be switched on and off individually. This way it is possible to select unique neurons in the vicinity of the probe for recording and stimulation without having to mechanically move the probe.

Potential applications of the probe include fundamental brain research, and also pre- or intraoperative localization of seizure foci for brain surgery.

Read more on Medgadget.

Read more in News Release from IMEC.

CRW.jpgUpgrade to CRW Stereotactic system

At the annual 2010 Congress of Neurological Surgeons Meeting in San Francisco Integra LifeSciences demonstrated an upgrade to its CRW stereotactic system - a multi-purpose stereotactic system used for localizing intra-cranial targets and precisely directing instruments to the target in cases such as brain biopsy, tumor resection, and Deep Brain Stimulation (DBS) surgeries.
According to the Press Release from Integra they have listened to feedback from neurosurgeons, and created an easier to use CRW® system while maintaining versatility and accuracy. The result is a system that can be set-up and ready to use in four easy steps, while being accurate to +/- 0.5mm at all its settings.

Read more in Medgadget.

Read Press Release from Integra.

VariLift.jpgFDA Clearance for VariLift® Stand-Alone Expandable Interbody Fusion System

Wenzel Spine announces the FDA clearance for the VariLift System as an Interbody Fusion Device for stand-alone use. The VariLift Interbody Fusion System is indicated for intervertebral body fusion of the lumbar spine, from L2 to S1, in skeletally mature patients who have had six months of non-operative treatment.

The device is intended for use at either one level or two contiguous levels for the treatment of degenerative disc disease (DDD) with up to Grade I spondylolisthesis. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies.

Read more on MedGadget.

PROcedure.jpgFDA approval for PROcedure Rehearsal Studio Software

Simbionix of Cleveland announces the FDA approval for the PROcedure Rehearsal Studio Software. The software allows clinicians to create a patient specific 3D anatomical model based on a patient’s CT for the purpose of simulating, analyzing and evaluating for upcoming surgical treatment options.

The 3D model created by the PROcedure Rehearsal Studio Software can also be exported to the Simbionix ANGIO Mentor Simulator practice environment, allowing the user to rehearse difficult procedures.

Read more on MedGadget

Activa.jpgEuropean CE Mark Approval for Deep Brain Stimulation Therapy for Refractory Epilepsy

In a News Release Medtronic announced that the company has received CE (Conformité Européenne) Mark approval for Medtronic Deep Brain Stimulation (DBS) Therapy in Europe as adjunctive treatment for partial-onset seizures in adults with medically refractory epilepsy.

DBS therapy for epilepsy delivers controlled electrical pulses to the anterior nucleus of the thalamus, which is part of a circuit involved in seizures.  

Medtronic DBS Therapy for refractory epilepsy is investigational in the United States and is under review by the U.S. Food and Drug Administration (FDA). 

Read more in News Release

Page 6 of 11

You are here: